Allevorin interleukin-3: Will start a Canadian Phase I/II trial

Cangene Corp. (TSE:CNJ), Toronto Product: Allevorin interleukin-3, to stimulate precursor blood cells Use: Enhance marrow recovery after radiation and chemotherapy in metastatic breast cancer Status: ...